Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease

被引:163
作者
Dorsey, E. Ray [1 ]
Venkataraman, Vinayak [1 ]
Grana, Matthew J. [3 ]
Bull, Michael T. [3 ]
George, Benjamin P. [6 ]
Boyd, Cynthia M. [2 ]
Beck, Christopher A. [4 ]
Rajan, Balaraman [5 ]
Seidmann, Abraham [5 ]
Biglan, Kevin M. [3 ]
机构
[1] Johns Hopkins Med, Dept Neurol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med, Dept Med, Baltimore, MD 21287 USA
[3] Univ Rochester, Med Ctr, Dept Neurol, New York, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, New York, NY USA
[5] Univ Rochester, William E Simon Grad Sch Business Adm, New York, NY USA
[6] Univ Rochester, Sch Med & Dent, New York, NY USA
关键词
DEEP-BRAIN-STIMULATION; CARE; TELEMEDICINE; SATISFACTION; VALIDATION;
D O I
10.1001/jamaneurol.2013.123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention: Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P=.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P=.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 44 条
  • [11] Association of specialist involvement and quality of care for Parkinson's disease
    Cheng, Eric M.
    Swarztrauber, Kari
    Siderowf, Andrew D.
    Eisa, Mahmood S.
    Lee, Martin
    Vassar, Stefanie
    Jacob, Erin
    Vickrey, Barbara G.
    [J]. MOVEMENT DISORDERS, 2007, 22 (04) : 515 - 522
  • [12] Patient satisfaction with teledermatology: quantitative and qualitative results from a randomized controlled trial
    Collins, K
    Walters, S
    Bowns, I
    [J]. JOURNAL OF TELEMEDICINE AND TELECARE, 2004, 10 (01) : 29 - 33
  • [13] Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial
    Constantinescu, Gabriella
    Theodoros, Deborah
    Russell, Trevor
    Ward, Elizabeth
    Wilson, Stephen
    Wootton, Richard
    [J]. INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS, 2011, 46 (01) : 1 - 16
  • [14] Comparison of office-based versus home web-based clinical assessments for Parkinson's disease
    Cubo, Esther
    Trejo Gabriel-Galan, Jose M.
    Seco Martinez, Joaquin
    Rioja Alcubilla, Carlos
    Yang, Chengwu
    Fernandez Arconada, Olga
    Mariscal Perez, Natividad
    [J]. MOVEMENT DISORDERS, 2012, 27 (02) : 308 - 311
  • [15] Treatment Disparities in Parkinson's Disease
    Dahodwala, Nabila
    Xie, Ming
    Noll, Elizabeth
    Siderowf, Andrew
    Mandell, David S.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 (02) : 142 - 145
  • [16] Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
    Dorsey, E. R.
    Constantinescu, R.
    Thompson, J. P.
    Biglan, K. M.
    Holloway, R. G.
    Kieburtz, K.
    Marshall, F. J.
    Ravina, B. M.
    Schifitto, G.
    Siderowf, A.
    Tanner, C. M.
    [J]. NEUROLOGY, 2007, 68 (05) : 384 - 386
  • [17] Group patient visits for Parkinson disease A randomized feasibility trial
    Dorsey, E. R.
    Deuel, L. M.
    Beck, C. A.
    Gardiner, I. F.
    Scoglio, N. J.
    Scott, J. C.
    Marshall, F. J.
    Biglan, K. M.
    [J]. NEUROLOGY, 2011, 76 (18) : 1542 - 1547
  • [18] A U.S. Survey of Patients with Parkinson's Disease: Satisfaction with Medical Care and Support Groups
    Dorsey, E. Ray
    Voss, Tiffini S.
    Shprecher, David R.
    Deuel, Lisa M.
    Beck, Christopher A.
    Gardiner, Irenita F.
    Coles, Margaret A.
    Burns, Richard S.
    Marshall, Frederick J.
    Biglan, Kevin M.
    [J]. MOVEMENT DISORDERS, 2010, 25 (13) : 2128 - 2135
  • [19] Increasing Access to Specialty Care: A Pilot, Randomized Controlled Trial of Telemedicine for Parkinson's Disease
    Dorsey, E. Ray
    Deuel, Lisa M.
    Voss, Tiffini S.
    Finnigan, Kara
    George, Benjamin P.
    Eason, Sheelah
    Miller, David
    Reminick, Jason I.
    Appler, Anna
    Polanowicz, Joyce
    Viti, Lucy
    Smith, Sandy
    Joseph, Anthony
    Biglan, Kevin M.
    [J]. MOVEMENT DISORDERS, 2010, 25 (11) : 1652 - 1659
  • [20] Fahn S, 2004, NEW ENGL J MED, V351, P2498